OneAscent Financial Services LLC Purchases 10,976 Shares of Colgate-Palmolive (NYSE:CL)

OneAscent Financial Services LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 284.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,829 shares of the company's stock after purchasing an additional 10,976 shares during the quarter. OneAscent Financial Services LLC's holdings in Colgate-Palmolive were worth $1,348,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Benjamin Edwards Inc. increased its stake in shares of Colgate-Palmolive by 10,946.5% in the 3rd quarter. Benjamin Edwards Inc. now owns 106,157 shares of the company's stock valued at $11,020,000 after purchasing an additional 105,196 shares during the last quarter. Ascent Group LLC grew its position in shares of Colgate-Palmolive by 3.1% in the 3rd quarter. Ascent Group LLC now owns 14,457 shares of the company's stock valued at $1,501,000 after buying an additional 435 shares during the last quarter. Centiva Capital LP lifted its stake in shares of Colgate-Palmolive by 762.4% in the 3rd quarter. Centiva Capital LP now owns 24,536 shares of the company's stock valued at $2,547,000 after purchasing an additional 21,691 shares during the period. Hilltop Holdings Inc. bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $3,009,000. Finally, HighTower Advisors LLC increased its holdings in shares of Colgate-Palmolive by 4.8% during the third quarter. HighTower Advisors LLC now owns 970,040 shares of the company's stock valued at $100,689,000 after acquiring an additional 44,482 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Remove Ads

Colgate-Palmolive Trading Down 3.1 %

Shares of NYSE CL traded down $2.81 during trading on Monday, hitting $88.85. 2,837,763 shares of the company traded hands, compared to its average volume of 5,197,015. The firm has a market capitalization of $72.06 billion, a P/E ratio of 25.18, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company has a 50-day moving average price of $90.27 and a 200-day moving average price of $93.13.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm posted $0.87 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive announced that its Board of Directors has initiated a stock repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be issued a dividend of $0.52 per share. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 annualized dividend and a yield of 2.34%. Colgate-Palmolive's payout ratio is presently 59.09%.

Analyst Ratings Changes

Several equities research analysts have commented on CL shares. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. Piper Sandler cut their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Finally, Barclays upped their price target on Colgate-Palmolive from $83.00 to $89.00 and gave the stock an "equal weight" rating in a research note on Thursday, March 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $102.06.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.